Daniel Burkhoff, MD PhD


Director, Heart Failure, Hemodynamics
and MCS Research

University / Hospital Affiliation

Cardiovascular Research Foundation


Daniel Burkhoff, MD, PhD, is Director, Heart Failure, Hemodynamics and MCS Research at the CRF Clinical Trials Center. He is also an Adjunct Associate Professor at Columbia University. A world-renowned expert in heart failure and hemodynamics, Dr. Burkhoff collaborates on heart failure research initiatives across all divisions of CRF. Dr. Burkhoff is author of Harvi, an interactive simulation-based application for teaching and researching many aspects of ventricular mechanics and hemodynamics. Dr. Burkhoff works with the CRF Center for Education to develop novel curricula using Harvi in educational programs for practicing physicians, fellows, and medical students around the world. Dr. Burkhoff’s interests include cardiovascular modeling and research in basic and clinical aspects of ventricular mechanics, cardiovascular monitoring, heart failure, device and pharmacologic treatments for heart failure, including left ventricular assist devices. He was instrumental in the creation of the CRF Skirball Center for Innovation and served as Director when it opened in 2005. Before returning to CRF, he was Vice President of Medical Science for HeartWare International. Previously, he served as Medical Director of CircuLite. He received his medical and doctor of philosophy degrees from The Johns Hopkins School of Medicine and completed his cardiology fellowship at The Johns Hopkins Hospital.

Related Content

Manuscripts & Publications

Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality

The purpose of this study was to investigate the association between obtaining hemodynamic data from early pulmonary artery catheter (PAC) placement and outcomes in cardiogenic shock (CS).

Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment

Congestion is the main reason for hospitalization in patients with acute decompensated heart failure and is an important target for therapy. However, achieving complete decongestion can be challenging.

Temporary mechanical circulatory support devices: practical considerations for all stakeholders

Originally intended for life-saving salvage therapy, the use of temporary mechanical circulatory support (MCS) devices has become increasingly widespread in a variety of clinical settings in the contemporary era.